Clinical Trials Logo

Clinical Trial Summary

White spot lesions (WSL) are characterized by an apparently intact outer surface and a demineralized subsurface, and are considered the first clinical sign of dental caries. Aim of this study is to determine the treatment potential of self-assembling peptide (P11-4), casein phosphopeptide-amorphos calcium fluoride phosphate (CPP-ACFP) and resin infiltration technique to reverse or arrest the WSLs in the same oral environments in pediatric patients using visual assessments and laser fluorescence investigation.


Clinical Trial Description

White spot lesions (WSL) are characterized by an apparently intact outer surface and a demineralized subsurface, and are considered the first clinical sign of dental caries. These lesions are characterized by white chalky appearance. As caries is reversible under favorable conditions, many approaches have focused on treating it as soon as possible1. Aim of this study is to determine the treatment potential of self-assembling peptide (P11-4), casein phosphopeptide-amorphos calcium fluoride phosphate (CPP-ACFP) and resin infiltration technique to reverse or arrest the WSLs in the same oral environments in pediatric patients. This will be achieved using visual assessments and laser fluorescence investigation. The proposed study is a randomized controlled clinical trial with split-mouth design. Included are forty positive patients aged 9-17 years, with at least four visible WSL on smooth surfaces in permanent teeth, requiring non-operative treatment. WSL will be assessed visually by ICDAS II, Nyvad criteria and laser fluorescence (LF pen). The lesions are randomly assigned into 4 groups (n = 40): Gr NT (no treatment, control group), Gr CR (Curodont Repair), Gr V (MI Varnish), Gr I (Icon) groups. Lesions will be assessed by International Caries Detection and Assessment System, Nyvad caries activity criteria and laser fluorescence at baseline and follow-up period after1, 3, 6 and 12 months. Data will be analyzed with intention-to-treat concept by Student T-test for paired samples, Wilcoxon signed rank test, P< .05. Pre-test on 20 subjects resulted in n=41 patients sample size. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05206539
Study type Interventional
Source Plovdiv Medical University
Contact Irina Uzunova, DMD
Phone +359899984312
Email [email protected]
Status Recruiting
Phase Phase 3
Start date April 20, 2022
Completion date April 20, 2024

See also
  Status Clinical Trial Phase
Completed NCT03004196 - Comparison of Efficacy Of Probiotic Toothpaste and Chlorhexidine Mouthwash To Reduce S.Mutans Phase 1/Phase 2
Not yet recruiting NCT03973554 - Caries Prevention Potential of Pearl Powder Versus CPP-ACP on Enamel White Spot Lesions Phase 2
Not yet recruiting NCT03930927 - Effect of Self Assembling Peptide on White Spot Lesion Early Phase 1
Not yet recruiting NCT03721198 - RMGI Varnish Versus APF Gel in Prevention of White Spot Lesions During Orthodontic Treatment N/A
Completed NCT03526276 - Effect of Different Pastes on Remineralization of Early Caries Lesions in Primary Teeth N/A
Recruiting NCT03823612 - Reminerlization Potential of Innovative Biomimetic Material in Caries White Spot Lesions Phase 4
Completed NCT04401280 - Bioactive Glass in the Treatment of Enamel White Spot Lesions Phase 3
Completed NCT03738839 - A Comparative Assessment of Orthodontic Treatment Outcomes Using the Quantitative Light-Induced Fluorescence Method N/A
Recruiting NCT04994314 - White Spot Lesions Prevention During Orthodontic Fixed Appliance Treatment: a Randomized Clinical Trial Phase 3
Completed NCT04992481 - Fluoride Varnish, Ozone, Octenidin and WSLs in Orthodontic Patients N/A
Recruiting NCT03217084 - Treatment of Postorthodontic White Spot Lesions Phase 4
Not yet recruiting NCT04827966 - Remineralization Agents for the Treatment of White Spot Lesions N/A